Balchem's consistent execution across all segments, strong cash flow, and low leverage support continued organic growth and M&A optionality. Monitor the upcoming conference call for any commentary on end-market demand trends and input cost outlook.
Price Chart
Executive Summary
Balchem reported another strong quarter with record net sales, net earnings, and adjusted EBITDA, driven by growth across all three segments. The 2.3% adjusted EPS beat vs consensus and continued strong free cash flow generation reinforce the positive momentum, though no formal guidance was provided.
Key Financial Metrics
Key Facts
- Q3 2026 net sales of $290.7M, up 8.6% YoY
- GAAP EPS of $1.46 vs $1.24 YoY; adjusted EPS of $1.57 vs $1.35 YoY
- Adjusted EBITDA of $80.3M, up 12.4% YoY
- Free cash flow of $57.9M, up from $50.7M YoY
- All three segments posted YoY sales and earnings growth
- Repurchased ~$28M of stock in Q3 and ~$127M over trailing 12 months
- Net debt reduced to $57.7M, leverage ratio of 0.2x
Financial Impact
Adjusted EPS of $1.57 beat consensus of $1.53 by 2.3%; revenue of $290.7M slightly above $289.2M consensus
Risk Factors
- No formal forward guidance provided; reliance on management commentary
- Higher manufacturing input costs partially offset margin gains
- Share repurchase activity may slow if cash is redirected to M&A
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000009326-26-000032 |
| Document: bcpc-20261023.htm | 0000009326-26-000032 |
| Document: 0000009326-26-000032-index-headers.html | 0000009326-26-000032 |
| Document: 0000009326-26-000032-index.html | 0000009326-26-000032 |
| Document: 0000009326-26-000032.txt | 0000009326-26-000032 |
| 8-K Data (Synthetic) | 0000009326-26-000032 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 3d ago | 8-K | $175.49 | awaiting T+20 | — | $177.00 (+0.86%) |
Oct 23, 2026 3d ago | Press Release | $175.49 | awaiting T+20 | — | $177.00 (+0.86%) |
Jul 31, 2026 12w ago | 8-K | $167.56 $178.44 | ▲ +6.50% | ▲ +3.51% | $177.00 (+5.64%) |
Jul 31, 2026 12w ago | Press Release | $167.56 $178.44 | ▲ +6.50% | ▲ +3.51% | $177.00 (+5.64%) |
Jul 24, 2026 13w ago | 8-K | $164.79 $177.50 | ▲ +7.71% | ▲ +4.41% | $177.00 (+7.41%) |
Jul 17, 2026 14w ago | Press Release | $163.35 $178.51 | ▲ +9.28% | ▲ +4.83% | $177.00 (+8.36%) |
May 20, 2026 22w ago | Court Ruling | $161.75 $165.57 | ▲ +2.36% | ▲ +2.14% | $177.00 (+9.43%) |
Apr 16, 2026 27w ago | Press Release | $174.45 | awaiting T+20 | — | $177.00 (+1.46%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers